Cancer factsheet: female breast. by unknown
  Family history 
 Nulliparity and low parity 
 Late age first pregnancy 
 Late natural menopause 
 Late menarche 
 Oral contraceptives 
 Diethylstilbestrol 
 Greater body fatness 
 Alcohol 
 Smoking 
 Ionizing radiation 
 Benign breast disease 
 High SES 
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Key facts 
 
Age profile at diagnosis and death 
Top risk factors 
Cases mapped by county 
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DEATHS
 Invasive Insitu 
Number of new cases per year 2919 357 
     Incidence rate (cases per 100,000 per year) 121.6 16.0 
     Cumulative lifetime risk of diagnosis (to age 74) 1 in 11 1 in 76 
     Percentage of all invasive cancers * 30.1% - 
     Ranking among most common cancers * 1st - 
Number of deaths per year 694 - 
     Mortality rate (deaths per 100,000 per year) 26.6 - 
     Cumulative lifetime risk of death (to age 74) 1 in 50 - 
     Percentage of all cancer deaths 17.1% - 
     Ranking among most common invasive cancer deaths 2nd - 
Number of people with this cancer still alive, end 2014 # 31457 3672 
     Number alive per 100,000 1350 158 
*invasive cancers only, excluding non-melanoma skin cancer 
# diagnosed since 1994 
Median age group=60-64 Median age group=70-74 
Annual average number of cases, 2005-2014: 
colours indicate higher or lower than 
expected based on national rates 
% of all cases diagnosed 2012-2014 
 
Information on cancer mortality provided by the Central 
Statistics Office. Incidence: 2012-2014 and mortality: 
2011-2013 averages unless otherwise stated 
Last updated May 2017 © 
National Cancer Registry, 
Ireland 
APC# Incidence invasive: (94-02) 2.8%, (02-05) -1.8%, (05-08) 5.7%, (08-14) -1.1% 
          Insitu: (94-06) 8.5%, (06-09) 18.3%, (09-14) -0.4% 
          Mortality: (94-13) -1.9% 
# Annual Percentage Change 
Treatment within 1 year 5 year net survival 
Trend in incidence and mortality Stage at diagnosis 
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Invasive Mortality Insitu
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percent of all cases diagnosed
 
46% Radiotherapy
57% Hormone 
therapy
66% Chemotherapy
84% Surgery
Diagnosed Net Survival 
(age standardised) 
95% 
Confidence 
interval 
1994-1998 71.6% 70.0-73.1% 
1999-2003 77.3% 75.9-78.6% 
2004-2008 80.8% 79.6-82.0% 
2009-2013 83.1% 81.5-84.5% 
 
*10 year net survival (hybrid analysis): 
  75.1% (73.1-77.2%) 
99% pathologically 
diagnosed 
Female breast 
